Alcon & STAAR leap on CMS ruling

Article

The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).

The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).

Similar to the CMS decision allowing cataract patients access to presbyopia-correcting IOLs, this new ruling will allow patients to pay the additional charges for the correction of pre-existing astigmatism while Medicare will provide customary reimbursement for the cataract surgery.

Both Alcon and STAAR Surgical believe that their Toric lenses (AcrySof Toric IOL, Alcon; STAAR Toric IOL, STAAR) will be included under this ruling. Such lenses allow a surgeon to replace the cataract lens and provide refractive correction for the astigmatic cornea in a single procedure.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.